1NKF-K/DOQI:Clinical Practice Guidelines for Anemia of Chronic Kidney Disease:update[J].Am J Kidney Dis,2000,37(Suppl.1):S182-238. 被引量：1
2Harnett JD,et al.Congestive heart failure in dialysis patients:prevalence,incidence,prognosis and risk factors[J].Kidney Int,1998,47:884. 被引量：1
3Vanholder R,et al.Contributing factors to the inhibition of phagocytosis in hemodialyzed patients[J].Kidney Int,2004,44:208. 被引量：1
4Lowrie EG,et al.The relative contribution of measured variables to death risk among hemodialysis patients,in Friedman E A:Death on hemodialysis:Preventable or inevitable[J].Boston,MA,Kluwer academic Publisher,1999,121. 被引量：1
5Cavil1 I,Macdougall IC.Erythropoiesis and iron supply in patients treated with eryyhropoietin[J].Erythropoiesis,1992,3:50. 被引量：1
4Fairbanks VF,Fahey JL,Beutler E.Clinical Disorders of Iron Matabolism NewYork:Grune and Stratton Inc,1971,46-54 被引量：1
5Aulbert E,Schimidt CG.Ferritin-A Tumor Marker in Myeloid Leukemia.Cancer Detectprev,1985,8(102):297-302 被引量：1
6Dormer MH,Abel U,Frize D,et al.Serum Ferritin in Relation to the Course of HodgkinsDisease.Cancer,1983,52(12),2308-2312 被引量：1
7Marcus DM,Zinberg N.Measurement of Serum Ferritin by Radioimmunoassay:results inNormal Individuals and Patients with Breast Cancer[J],Nat 1 Cancer Inst,1975,55:791-795 被引量：1
